[HTML][HTML] Type II diabetes mellitus: a review on recent drug based therapeutics

S Padhi, AK Nayak, A Behera - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Diabetes mellitus (DM) is a metabolic disorder that occurs in the body because of decreased
insulin activity and/or insulin secretion. Pathological changes such as nephropathy …

Mucoadhesive carriers for oral drug delivery

R Kumar, T Islam, M Nurunnabi - Journal of Controlled Release, 2022 - Elsevier
Among the various dosage forms, oral medicine has extensive benefits including ease of
administration and patients' compliance, over injectable, suppositories, ocular and nasal …

Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: Formulation development, stability issues, basic considerations and applications

VK Rai, N Mishra, KS Yadav, NP Yadav - Journal of controlled release, 2018 - Elsevier
The use of nanoemulsion in augmenting dermal and transdermal effectiveness of drugs has
now well established. The development of nanoemulsion based semisolid dosage forms is …

Cubosomes in drug delivery—a comprehensive review on its structural components, preparation techniques and therapeutic applications

D Sivadasan, MH Sultan, SS Alqahtani, S Javed - Biomedicines, 2023 - mdpi.com
Cubosomes are lipid vesicles that are comparable to vesicular systems like liposomes.
Cubosomes are created with certain amphiphilic lipids in the presence of a suitable …

Drug delivery systems for programmed and on-demand release

P Davoodi, LY Lee, Q Xu, V Sunil, Y Sun, S Soh… - Advanced drug delivery …, 2018 - Elsevier
With the advancement in medical science and understanding the importance of
biodistribution and pharmacokinetics of therapeutic agents, modern drug delivery research …

Treatment strategies against diabetes: Success so far and challenges ahead

R Khursheed, SK Singh, S Wadhwa, B Kapoor… - European journal of …, 2019 - Elsevier
The growing disease burden of diabetes mellitus is an important public health concern,
affecting over 400 million people globally. This epidemic, if not controlled in time, leads to …

[HTML][HTML] Lipid-based nanoparticles as a pivotal delivery approach in triple negative breast cancer (TNBC) therapy

A Chaudhuri, DN Kumar, RA Shaik, BG Eid… - International journal of …, 2022 - mdpi.com
Triple-negative breast cancer is considered the most aggressive type of breast cancer
among women and the lack of expressed receptors has made treatment options …

Microneedle array: applications, recent advances, and clinical pertinence in transdermal drug delivery

J Halder, S Gupta, R Kumari, GD Gupta… - Journal of Pharmaceutical …, 2021 - Springer
Drug delivery through the skin by transdermal patches has a long history. Subsequent
growth of transdermal science proved prominent utility of transdermal systems meant for …

Wearable glucose monitoring and implantable drug delivery systems for diabetes management

J Zhang, J Xu, J Lim, JK Nolan, H Lee… - Advanced Healthcare …, 2021 - Wiley Online Library
The global cost of diabetes care exceeds 1trillioneachyearwithmorethan 327 billion being
spent in the United States alone. Despite some of the advances in diabetes care including …

Drug delivery system in the treatment of diabetes mellitus

R Zhao, Z Lu, J Yang, L Zhang, Y Li… - … in bioengineering and …, 2020 - frontiersin.org
Diabetes mellitus has been described as a chronic endocrine and metabolic disease, which
is characterized by hyperglycemia and the coexistence of multiple complications. At present …